These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2048159)
1. Hepatic protein pattern alterations following perfluorodecanoic acid exposure in rats. Witzmann FA; Parker DN Toxicol Lett; 1991 Jun; 57(1):29-36. PubMed ID: 2048159 [TBL] [Abstract][Full Text] [Related]
2. Pathological and hepatic ultrastructural effects of a single dose of perfluoro-n-decanoic acid in the rat, hamster, mouse, and guinea pig. Van Rafelghem MJ; Mattie DR; Bruner RH; Andersen ME Fundam Appl Toxicol; 1987 Oct; 9(3):522-40. PubMed ID: 3692011 [TBL] [Abstract][Full Text] [Related]
3. Charge modification in rodent hepatic Grp78/BiP following exposure to structurally diverse peroxisome proliferators. Witzmann FA; Jarnot BM; Clack JW Appl Theor Electrophor; 1994; 4(2):81-8. PubMed ID: 7880882 [TBL] [Abstract][Full Text] [Related]
4. Modification of hepatic immunoglobulin heavy chain binding protein (BiP/Grp78) following exposure to structurally diverse peroxisome proliferators. Witzmann FA; Jarnot BM; Parker DN; Clack JW Fundam Appl Toxicol; 1994 Jul; 23(1):1-8. PubMed ID: 7958552 [TBL] [Abstract][Full Text] [Related]
5. Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels. Kawashima Y; Kobayashi H; Miura H; Kozuka H Toxicology; 1995 May; 99(3):169-78. PubMed ID: 7610463 [TBL] [Abstract][Full Text] [Related]
6. Effect of the peroxisome proliferator perfluoro-n-decanoic acid on glucose transport in the isolated perfused rat liver. Goecke-Flora CM; Wyman JF; Jarnot BM; Reo NV Chem Res Toxicol; 1995; 8(1):77-81. PubMed ID: 7703370 [TBL] [Abstract][Full Text] [Related]
7. Effects of peroxisome proliferators on rat liver phospholipids: sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid. Adinehzadeh M; Reo NV Chem Res Toxicol; 1998 May; 11(5):428-40. PubMed ID: 9585473 [TBL] [Abstract][Full Text] [Related]
8. Effects of perfluoro-n-decanoic acid on the respiratory activity of isolated rat liver mitochondria. Langley AE J Toxicol Environ Health; 1990; 29(3):329-36. PubMed ID: 2313742 [TBL] [Abstract][Full Text] [Related]
9. Induction of enoyl-CoA hydratase by LD50 exposure to perfluorocarboxylic acids detected by two-dimensional electrophoresis. Witzmann FA; Parker DN; Jarnot BM Toxicol Lett; 1994 May; 71(3):271-7. PubMed ID: 8160215 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats. Gutshall DM; Pilcher GD; Langley AE J Toxicol Environ Health; 1989; 28(1):53-65. PubMed ID: 2506363 [TBL] [Abstract][Full Text] [Related]
11. Effects of perfluorodecanoic acid on thyroid status in rats. Van Rafelghem MJ; Inhorn SL; Peterson RE Toxicol Appl Pharmacol; 1987 Mar; 87(3):430-9. PubMed ID: 3564018 [TBL] [Abstract][Full Text] [Related]
12. Toxicant-induced alterations in two-dimensional electrophoretic patterns of hepatic and renal stress proteins. Witzmann FA; Fultz CD; Lipscomb JC Electrophoresis; 1996 Jan; 17(1):198-202. PubMed ID: 8907540 [TBL] [Abstract][Full Text] [Related]
13. Perfluorodecanoic acid, a peroxisome proliferator, activates phospholipase C, inhibits CTP:phosphocholine cytidylyltransferase, and elevates diacylglycerol in rat liver. Reo NV; Narayanan L; Kling KB; Adinehzadeh M Toxicol Lett; 1996 Jul; 86(1):1-11. PubMed ID: 8685914 [TBL] [Abstract][Full Text] [Related]
14. Dose-response hapatotoxicity of the peroxisome proliferator, perfluorodecanoic acid and the relationship to phospholipid metabolism in rats. Adinehzadeh M; Reo NV; Jarnot BM; Taylor CA; Mattie DR Toxicology; 1999 Jun; 134(2-3):179-95. PubMed ID: 10403636 [TBL] [Abstract][Full Text] [Related]
15. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats. Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245 [TBL] [Abstract][Full Text] [Related]
16. The effects of perfluorodecanoic acid (PFDA) on humoral, cellular, and innate immunity in Fischer 344 rats. Nelson DL; Frazier DE; Ericson JE; Tarr MJ; Mathes LE Immunopharmacol Immunotoxicol; 1992; 14(4):925-38. PubMed ID: 1294628 [TBL] [Abstract][Full Text] [Related]
17. Induction of hepatic acyl-CoA-binding protein and liver fatty acid-binding protein by perfluorodecanoic acid in rats. Lack of correlation with hepatic long-chain acyl-CoA levels. Sterchele PF; Vanden Heuvel JP; Davis JW; Shrago E; Knudsen J; Peterson RE Biochem Pharmacol; 1994 Aug; 48(5):955-66. PubMed ID: 8093108 [TBL] [Abstract][Full Text] [Related]
18. Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Maher JM; Aleksunes LM; Dieter MZ; Tanaka Y; Peters JM; Manautou JE; Klaassen CD Toxicol Sci; 2008 Dec; 106(2):319-28. PubMed ID: 18757529 [TBL] [Abstract][Full Text] [Related]
19. The effects of perfluoro-n-decanoic acid (PFDA) on rat heart beta-receptors, adenylate cyclase, and fatty acid composition. Pilcher GD; Gutshall DM; Langley AE Toxicol Appl Pharmacol; 1987 Sep; 90(2):198-205. PubMed ID: 2820085 [TBL] [Abstract][Full Text] [Related]
20. Effects of perfluorodecanoic acid on hepatic indices of thyroid status in the rat. Kelling CK; Van Rafelghem MJ; Menahan LA; Peterson RE Biochem Pharmacol; 1987 Apr; 36(8):1337-44. PubMed ID: 3593420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]